Cougar Biotechnology - Ownership and Business Overview

Life ScienceCompany

Cougar Biotechnology Ownership

Who owns Cougar Biotechnology?

Cougar Biotechnology is owned by Johnson & Johnson. It was acquired on May 31, 2009.

Cougar Biotechnology Business Overview

Where is Cougar Biotechnology headquartered?

Cougar Biotechnology is headquartered in Raritan, New Jersey.

How many employees does Cougar Biotechnology have?

Cougar Biotechnology has 54 employees.

What sector is Cougar Biotechnology in?

Cougar Biotechnology is a life science company.

When was Cougar Biotechnology founded?

Cougar Biotechnology was founded in 2003.

Life Science M&A Summary in 2009

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Cougar Biotechnology, Inc.

Mailstop E1756, 920 Route 202,
Raritan, New Jersey 08869
United States,
www.cougarbiotechnology.com

Cougar Biotechnology (CGRB) is a biotechnology company established to in-license and develop oncology drugs. Cougar's oncology portfolio includes CB7630, a targeted enzyme inhibitor, which is currently being tested in Phase II clinical trials in prostate cancer; other products are being tested for hematological and solid tumors.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.